{
    "clinical_study": {
        "@rank": "144705", 
        "arm_group": [
            {
                "arm_group_label": "Low-fat milk group", 
                "arm_group_type": "Active Comparator", 
                "description": "The low-fat milk group was instructed to consume 2 packs of low-fat milk per day (200 mL twice daily) for 6 weeks."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "Control group maintained their usual diet without low-fat milk supplement."
            }
        ], 
        "brief_summary": {
            "textblock": "This study aimed to investigate the effects of low-fat milk consumption on metabolic\n      parameters and biomarkers related to inflammation, oxidative stress, and endothelial\n      function in Korean adults with metabolic syndrome."
        }, 
        "brief_title": "Effects of Low Fat Milk Consumption on Metabolic Syndrome", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Metabolic Syndrome", 
        "condition_browse": {
            "mesh_term": "Metabolic Syndrome X"
        }, 
        "detailed_description": {
            "textblock": "A randomized, controlled, parallel, dietary intervention study was designed. Subjects with\n      metabolic syndrome and body mass index \u226523 kg/m2 were randomized to the low-fat milk group,\n      which were instructed to consume 2 packs of low-fat milk per day (200 mL twice daily) for 6\n      weeks, and the control group was instructed to maintain their habitual diet. Metabolic\n      markers were evaluated at baseline and at the end of the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects were enrolled if their body mass index (BMI) was \u226523 kg/m2 and they met the\n             criteria for metabolic syndrome.\n\n        Exclusion Criteria:\n\n          -  Those who were allergic to milk; those who had a history of digestive disorder; those\n             with a medical history of cardiovascular diseases, including coronary artery\n             diseases, valvular heart diseases, heart failure, or stroke; those who had cancer in\n             the past 5 years; those who were taking hypoglycemic agents for diabetes mellitus;\n             those who had chronic disease such as renal failure or liver cirrhosis; and those\n             with a hemoglobin A1c (HbA1c) level \u2265 7% were excluded from the research. People who\n             had a weight change > 5% of the total weight within the past 3 months, those who had\n             started taking or had changed their dose of anti-hypertensive agents or medications\n             for dyslipidemia within the previous 1 month, those who had a newly diagnosed\n             dyslipidemia requiring drug treatment, those who had taken steroids either orally or\n             by injection within the previous 3 months, those who were pregnant or were expecting\n             to become pregnant; and those who regularly consumed milk in quantities \u2265 200 mL per\n             day at least 3 times a week on average were also excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "58", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02028585", 
            "org_study_id": "12162-mfds-118", 
            "secondary_id": "12161MFDS118"
        }, 
        "intervention": {
            "arm_group_label": "Low-fat milk group", 
            "intervention_name": "Low-fat milk group", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "low-fat milk", 
            "metabolic syndrome", 
            "lipid profile", 
            "inflammation", 
            "oxidative stress", 
            "endothelial function"
        ], 
        "lastchanged_date": "December 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ansan-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "425-707"
                }, 
                "name": "Department of Endocrinology and Metabolism, Korea University Ansan Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Low-fat Milk Consumption on Metabolic and Atherogenic Biomarkers in Korean Adults With Metabolic Syndrome: a Randomized Controlled Trial", 
        "overall_official": {
            "affiliation": "Department of Endocrinology and Metabolism, Korea University Ansan Hospital", 
            "last_name": "Nan Hee Kim, Prof", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "lipid profiles, body mass index, waist circumference, blood pressure, fasting glucose, insulin, hemoglobin A1c and homeostasis model assessment of insulin resistance", 
                "measure": "metabolic parameters", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "description": "white blood cell count, high-sensitive C-reactive protein, Interleukin-6, adiponectin, serum and urine malondialdehyde, oxidized low-density lipoprotein, vascular cell adhesion molecule (VCAM) and intercellular adhesion molecule (ICAM)", 
                "measure": "inflammation markers", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "description": "EndoPAT index was assessed to evaluate endothelial function by using a finger plethysmograph based on non-invasive peripheral artery tonometry.", 
                "measure": "Endo-peripheral artery tonometry (EndoPAT) index", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02028585"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Korea University", 
            "investigator_full_name": "Nan Hee Kim", 
            "investigator_title": "Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ministry of Food and Drug Safety, Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ministry of Food and Drug Safety, Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}